Helixgate https://validator.w3.org/feed/docs/rss2.html STAT+: DOJ’s swift win in OhioHealth case should have hospitals studying their contracts, experts say Personalized Cartilage Graft Developed for Life-Threatening Infant Airway Narrowing FTC, four state AGs sue transgender health group over care standards Luigi Mangione will assert psychiatric defense in murder case in UnitedHealthcare CEO’s killing UniQure to file gene therapy for approval, reflecting major shifts at FDA Analytics Map Purification Optimization Tradeoffs Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B Age-Related Inflammation Linked to R-Loop Nucleic Acids, Opens Therapies UniQure plans resubmission for Huntington’s gene therapy after FDA reverses course—again UniQure plans Q3 submission for Huntington’s gene therapy after FDA reverses course—again STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcomm STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and more Be Bio bins hemophilia B cell therapy trial—the biotech’s lead program STAT+: Is Abridge’s ‘patient centered’ claim a bridge too far? Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more PwC declares biopharma ecosystem ‘back to full health’ as M&A buoys sector A new Westlake-backed biotech takes aim at migraines Putting the wrong foot forward: 5 tricky interview questions Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments Pancreatic Cancer Cell Death Triggered by Caspase‑8 Blockade in Preclinical Models Six Takeaways from the Danaher Bioprocessing Summit Single-Cell RNA Sequencing Reveals Gene Activity Changes in Crohn’s Disease STAT+: How a biotech turned a trial failure into an AI model Lilly buys non-opioid pain drugmaker 4E FDA, Moderna appear aligned on mRNA flu shot heading into adcomm The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations Amenable FDA review bodes well for Moderna’s mRNA flu shot ahead of adcomm grilling STAT+: ARCH-launched Neumora stops depression program Scramblase Dynamics Uncovered by Single-Vesicle Fluorescence Microscopy Mirum, Incyte bolster case for approval in rare bone disease despite mid-stage miss Alto’s depression candidate bolstered by independent study showing mood benefits How supplement use changed over decades Vertex presents new data on Casgevy in children [Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focus Scientists found a way to explain bird flocks that “defy” Newton’s third law STAT+: Human Cell Atlas leader’s tie to 10x Genomics raises conflict-of-interest questions 6 times when drug development got personal Therapy-Resistant Residual Cancer Cell Dependencies Mapped Silica Nanoparticles Induce Ferroptosis, Reprogram Immunity in Prostate Cancer Models Light-powered metabolism in the mammalian eye Home When Process Design Fails: 5 Common Planning Gaps That Create Downstream Purification Bottlenecks mRNA Flu Vaccine Shows Stronger, Longer-Lasting Immune Response ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canada STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canada STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end Neumora discards depression asset, lays off staffers after pair of late-stage flops